Marshall Wace’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-581,573
| Closed | -$59.1M | – | 3343 |
|
|
2025
Q4 | $59.1M | Buy |
581,573
+11,936
| +2% | +$959K | 0.05% | 306 |
|
|
2025
Q3 | $31.2M | Buy |
569,637
+139,918
| +33% | +$6.99M | 0.03% | 480 |
|
|
2025
Q2 | $22.8M | Buy |
429,719
+403,724
| +1,553% | +$20.5M | 0.03% | 539 |
|
|
2025
Q1 | $1.13M | Sell |
25,995
-75,178
| -74% | -$3.81M | ﹤0.01% | 1732 |
|
|
2024
Q4 | $5.68M | Buy |
+101,173
| New | +$6.3M | 0.01% | 1004 |
|
|
2023
Q3 | – | Sell |
-975,054
| Closed | -$91.6M | – | 2334 |
|
|
2023
Q2 | $91.6M | Buy |
+975,054
| New | +$76.1M | 0.18% | 115 |
|
|
2022
Q4 | – | Sell |
-33,823
| Closed | -$1.1M | – | 3077 |
|
|
2022
Q3 | $1.1M | Buy |
33,823
+27,621
| +445% | +$1.14M | ﹤0.01% | 2362 |
|
|
2022
Q2 | $245K | Buy |
+6,202
| New | +$332K | ﹤0.01% | 3095 |
|
|
2022
Q1 | – | Sell |
-4,007
| Closed | -$312K | – | 3529 |
|
|
2021
Q4 | $312K | Sell |
4,007
-114,413
| -97% | -$10.1M | ﹤0.01% | 3019 |
|
|
2021
Q3 | $11.3M | Buy |
118,420
+116,684
| +6,721% | +$12.3M | 0.05% | 488 |
|
|
2021
Q2 | $216K | Sell |
1,736
-25,014
| -94% | -$2.99M | ﹤0.01% | 2424 |
|
|
2021
Q1 | $3.52M | Sell |
26,750
-138,651
| -84% | -$19M | 0.02% | 1028 |
|
|
2020
Q4 | $21.9M | Buy |
+165,401
| New | +$20M | 0.12% | 174 |
|
|
2020
Q2 | – | Sell |
-46,963
| Closed | -$2.72M | – | 1660 |
|
|
2020
Q1 | $2.72M | Buy |
46,963
+19,140
| +69% | +$1.55M | 0.03% | 533 |
|
|
2019
Q4 | $2.57M | Buy |
+27,823
| New | +$2.45M | 0.02% | 732 |
|
|
2019
Q1 | – | Sell |
-6,964
| Closed | -$439K | – | 1817 |
|
|
2018
Q4 | $439K | Buy |
+6,964
| New | +$478K | ﹤0.01% | 1155 |
|
|
2017
Q1 | – | Sell |
-97,867
| Closed | -$1.31M | – | 439 |
|
|
2016
Q4 | $1.31M | Buy |
+97,867
| New | +$1.58M | 0.01% | 725 |
|
|
2015
Q4 | – | Sell |
-81,900
| Closed | -$1.47M | – | 1013 |
|
|
2015
Q3 | $1.47M | Buy |
+81,900
| New | +$1.88M | 0.02% | 532 |
|
|
2014
Q2 | – | Sell |
-19,433
| Closed | -$275K | – | 966 |
|
|
2014
Q1 | $275K | Buy |
+19,433
| New | +$262K | 0.01% | 711 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Marshall Wace's EXAS Position: Q1 2026 in Review
Marshall Wace sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 581,573 shares — an estimated $59.1M sold.
Marshall Wace first reported a position in EXAS in Q1 2014 and held it in 19 quarters. The position peaked at $91.6M in Q2 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Marshall Wace reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Marshall Wace sold 581,573 Exact Sciences shares in Q1 2026, an estimated $59.1M.
- Marshall Wace first reported a position in Exact Sciences in Q1 2014 and held it in 19 quarters.
- Marshall Wace's Exact Sciences position peaked at $91.6M in Q2 2023.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.